Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients Educational session

Dissecting the heterogeneity of HER2+ breast cancer (ID 150)

Lecture Time
16:30 - 16:55
Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients
Location
Madrid Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
16:30 - 18:00